Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China
Tóm tắt
Từ khóa
Tài liệu tham khảo
Asia-Pacific Working Party on NAFLD, 2007, How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?, J Gastroenterol Hepatol, 22, 788, 10.1111/j.1440-1746.2007.05042.x
2013, Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China, J Gastroenterol Hepatol, 28, 1654, 10.1111/jgh.12290
2013, What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?, World J Gastroenterol, 19, 3375, 10.3748/wjg.v19.i22.3375
2007, Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis, JAMA, 298, 2654, 10.1001/jama.298.22.2654
2009, Non alcoholic fatty liver disease and metabolic syndrome, Hippokratia, 13, 9
2014, Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA, BMC Med, 12, 154, 10.1186/s12916-014-0154-x
2011, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis, Hepatology, 54, 1082, 10.1002/hep.24452
Chinese Society of Hepatology, Fatty Liver and Alcoholic Fatty Liver Group, 2012, Guidelines for diagnosis and treatment of non-alcoholic fatty liver disease in China (revised edition 2010), Chinese J Front Med Sci, 4, 4
2009, Regular alcohol consumption is associated with increasing quality of life and mood in older men and women: the Rancho Bernardo Study, Maturitas, 62, 294, 10.1016/j.maturitas.2009.01.005
Asia-Pacific Working Party on NAFLD, 2007, Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary, J Gastroenterol Hepatol, 22, 775, 10.1111/j.1440-1746.2007.05002.x
Asia-Pacific Working Party for NAFLD, 2007, What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?, J Gastroenterol Hepatol, 22, 794, 10.1111/j.1440-1746.2007.04952.x
2009, Epidemiology of non-alcoholic fatty liver disease in China, J Hepatol, 50, 204, 10.1016/j.jhep.2008.10.010
2012, Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese population, Clin Exp Pharmacol Physiol, 39, 930, 10.1111/1440-1681.12011
2014, A model-free estimation for the covariate-adjusted Youden index and its associated cut-point, Stat Med, 33, 4963, 10.1002/sim.6290
2013, The epidemiological characteristics of fatty liver and relevant risk factors of the medical examination population in Shenzhen, Modern Preventive Medicine, 40, 1003
2007, Prevalence of fatty liver disease and its risk factors in the population of South China, World J Gastroenterol, 13, 6419, 10.3748/wjg.v13.i47.6419
2005, Prevalence of and risk factors for fatty liver in a general population of Shanghai, China, J Hepatol, 43, 508, 10.1016/j.jhep.2005.02.042
2010, [Anaerobic co-digestion of corn stalk and vermicompost], Huan Jing Ke Xue, 31, 520
2012, Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography, Gut, 61, 409, 10.1136/gutjnl-2011-300342
1987, Elevated serum uric acid - a facet of hyperinsulinaemia, Diabetologia, 30, 713, 10.1007/BF00296994
1995, Effect of insulin on uric acid excretion in humans, Am J Physiol, 268, E1
2000, Fatty infiltration of liver in hyperlipidemic patients, Digestive Diseases and Sciences, 45, 1929, 10.1023/A:1005661516165
2014, Connection between non-alcoholic fatty liver disease and diabetes mellitus, Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 21, 121, 10.2478/rjdnmd-2014-0017
2015, Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 8, 213
2015, ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population, Sci Rep, 5, 16494, 10.1038/srep16494